▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
g 11.7265625
▁countries 10.09375
. 2.1796875
▁The 2.6015625
▁introduction 7.59375
▁of 0.27197265625
▁the 1.607421875
▁study 6.83984375
▁describes 8.1484375
▁the 0.826171875
▁apparent 9.2109375
▁link 6.38671875
▁between 0.50341796875
▁pain 6.36328125
▁and 0.75
▁dem 8.46875
oral 3.6015625
ization 0.28173828125
. 1.408203125
▁Chron 6.1015625
ic 0.036163330078125
▁pain 0.347900390625
▁is 1.287109375
▁always 6.453125
▁accompanied 2.388671875
▁by 0.062042236328125
▁negative 4.8515625
▁emot 1.5302734375
ional 1.302734375
▁experiences 2.962890625
▁and 2.171875
▁blocks 11.0703125
▁a 4.125
▁person 1.349609375
’ 24.28125
s 1.998046875
▁ability 1.8505859375
▁to 0.04473876953125
▁receive 6.15234375
▁joy 4.81640625
▁and 1.39453125
▁satisfaction 3.02734375
▁from 1.189453125
▁life 0.99072265625
. 0.31298828125
▁The 1.8505859375
▁research 3.943359375
▁investig 5.12890625
ates 0.407958984375
▁the 0.4814453125
▁development 5.953125
▁of 0.17919921875
▁de 3.814453125
pression 0.234619140625
▁and 1.298828125
▁anx 2.33203125
iety 0.00591278076171875
▁among 2.376953125
▁patients 2.369140625
▁receiving 4.48828125
▁ph 6.67578125
arma 1.8017578125
ce 0.010894775390625
ut 0.0009427070617675781
ical 0.0146331787109375
▁op 5.05859375
io 0.20361328125
ids 0.6708984375
▁and 2.392578125
▁medical 6.1171875
▁mar 1.400390625
iju 0.05718994140625
ana 0.0003123283386230469
▁( 4.41015625
MM 0.7470703125
) 3.30859375
▁as 2.841796875
▁severe 9.890625
▁pain 1.62109375
kill 2.97265625
ers 0.0032558441162109375
. 0.5537109375
▁It 3.2421875
▁comp 5.08203125
ares 0.0538330078125
▁the 0.625
▁e 8.6640625
f 3.82421875
af 8.5859375
i 5.1015625
R 8.7421875
c 4.70703125
acy 4.0234375
▁of 0.38232421875
▁pres 5.46875
cri 1.2626953125
ptions 1.1318359375
▁and 2.41015625
▁exam 5.875
ines 0.035186767578125
▁the 0.49072265625
▁possibility 4.14453125
▁of 0.1171875
▁post 7.25
- 0.998046875
tre 2.814453125
at 0.0254364013671875
ment 0.049530029296875
▁de 1.927734375
pression 0.08099365234375
. 1.9521484375
<0x0A> 2.359375
There 4.8046875
▁is 1.04296875
▁currently 4.6875
▁a 1.2587890625
▁severe 5.01171875
▁lack 3.248046875
▁of 0.0289459228515625
▁information 2.029296875
▁about 1.388671875
▁the 0.5087890625
▁effects 3.1171875
▁of 0.073486328125
▁op 1.8359375
i 3.810546875
ates 0.28955078125
. 3.880859375
▁They 4.92578125
▁manage 9.1328125
▁pain 3.1953125
▁successfully 5.7578125
, 1.09765625
▁but 0.335205078125
▁the 2.708984375
▁past 9.3984375
▁few 2.49609375
▁dec 0.79541015625
ades 0.0006527900695800781
▁indicated 9.6328125
▁the 2.09765625
▁growing 4.74609375
▁concern 3.607421875
▁regarding 2.974609375
▁op 3.544921875
iate 0.78564453125
▁ab 1.5
use 0.00928497314453125
▁in 3.373046875
▁forms 10.6875
▁of 0.408935546875
▁over 3.314453125
d 0.400146484375
ose 0.167724609375
▁and 0.71337890625
▁add 1.130859375
iction 0.033966064453125
. 0.21728515625
▁A 3.998046875
▁more 5.69140625
▁manage 8.9609375
able 0.01125335693359375
▁and 2.25390625
▁sa 2.2109375
fer 0.001495361328125
▁alternative 1.658203125
▁might 6.453125
▁be 0.178955078125
▁medical 2.73046875
▁mar 0.1778564453125
iju 0.01351165771484375
ana 0.002796173095703125
. 1.51953125
▁However 2.8046875
, 0.0078582763671875
▁the 1.6220703125
▁l 9.828125
O 5.5
eg 7.34375
al 3.41015625
▁status 4.6953125
▁and 3.388671875
▁novel 8.8203125
ty 0.6982421875
▁of 0.195068359375
▁this 1.9716796875
▁drug 2.125
▁do 5.046875
▁not 0.08319091796875
▁allow 0.85693359375
▁finding 9.0234375
▁a 2.478515625
▁large 3.6953125
▁number 1.255859375
▁of 0.01108551025390625
▁studies 1.29296875
▁on 1.57421875
▁its 0.95458984375
▁effect 2.1484375
iveness 0.53271484375
. 1.0224609375
▁Specifically 8.1796875
, 0.1312255859375
▁it 2.765625
▁concerns 5.4296875
▁the 0.60009765625
▁emot 7.34375
ional 0.0214996337890625
▁condition 5.47265625
▁of 0.341064453125
▁patients 0.75830078125
▁experien 6.3046875
cing 0.0022792816162109375
▁chron 1.1396484375
ic 0.00844573974609375
▁pain 0.11395263671875
. 0.75732421875
▁This 3.193359375
▁research 2.919921875
▁paper 6.50390625
▁a 2.1171875
ims 0.002208709716796875
▁to 0.10430908203125
▁analyze 3.228515625
▁levels 9.4453125
▁of 0.03857421875
▁de 0.5966796875
pression 0.035430908203125
▁and 0.279052734375
▁anx 0.046722412109375
iety 0.005748748779296875
▁among 0.73974609375
▁people 3.3203125
▁receiving 0.859375
▁ther 7.9375
apy 0.32275390625
▁by 5.0078125
▁comparing 8.28125
▁the 1.0341796875
▁effects 2.30859375
▁of 0.04583740234375
▁ph 2.333984375
arma 0.05474853515625
ce 0.0040740966796875
ut 0.0023288726806640625
ical 0.0034351348876953125
▁op 0.287841796875
io 0.1209716796875
ids 0.0609130859375
▁and 0.26318359375
▁MM 1.3017578125
. 1.1123046875
<0x0A> 1.1748046875
The 1.3974609375
▁study 2.31640625
▁was 2.35546875
▁conducted 0.78466796875
▁in 1.5751953125
▁the 1.4326171875
▁form 2.43359375
▁of 0.02105712890625
▁co 9.953125
lection 8.6171875
▁and 1.92578125
▁analysis 0.94677734375
▁of 0.29345703125
▁sw 11.78125
tat 10.1875
ist 3.8125
ical 0.11724853515625
▁data 0.318359375
. 0.734375
▁Part 4.98828125
icip 0.1043701171875
ants 0.0579833984375
▁were 0.77392578125
▁rec 3.412109375
ru 0.03240966796875
ited 0.005435943603515625
▁for 4.11328125
▁six 7.76171875
▁months 0.66845703125
▁at 3.59765625
▁two 2.5703125
▁major 5.68359375
▁pain 2.994140625
▁relief 5.10546875
▁cent 1.451171875
ers 0.1300048828125
▁in 0.72900390625
▁Israel 4.484375
. 0.4541015625
▁The 1.197265625
▁research 2.091796875
ers 1.373046875
▁used 2.77734375
▁The 7.82421875
▁De 4.484375
pression 0.0305023193359375
▁Module 9.578125
▁of 0.99267578125
▁the 0.317626953125
▁Pat 2.267578125
ient 0.0138702392578125
▁Health 0.1026611328125
▁Question 0.02587890625
naire 0.056243896484375
▁and 3.43359375
▁the 0.70654296875
▁General 1.7568359375
ized 0.6650390625
▁An 0.0233001708984375
x 0.003887176513671875
iety 0.0075836181640625
▁Dis 0.701171875
order 0.05303955078125
▁Sc 1.2451171875
ale 0.10748291015625
▁to 1.7734375
▁interview 6.984375
▁participants 2.041015625
, 3.68359375
▁evaluate 5.625
▁their 0.69482421875
▁answers 6.5078125
, 0.95068359375
▁and 0.171142578125
▁conduct 4.42578125
▁the 2.091796875
▁study 2.501953125
. 0.2266845703125
▁To 5.265625
▁specifically 10.1796875
▁evaluate 2.65625
▁and 4.35546875
▁compare 0.90478515625
▁the 0.356201171875
▁probabil 12.6015625
ite 5.6796875
is 6.171875
▁of 0.1768798828125
▁de 1.2138671875
pression 0.047821044921875
▁or 5.00390625
▁anx 0.0567626953125
iety 0.007175445556640625
▁among 1.6044921875
▁the 2.32421875
▁diverse 8.8203125
▁groups 1.5537109375
, 1.5166015625
▁the 1.08203125
▁study 2.806640625
▁used 1.4873046875
▁multiple 4.453125
▁log 2.439453125
istic 0.08197021484375
▁regression 0.170654296875
▁analysis 0.791015625
▁and 2.52734375
▁chose 8.859375
▁medical 7.90625
▁mar 0.363525390625
iju 0.044403076171875
ana 0.01430511474609375
▁as 0.84912109375
▁the 1.0419921875
▁con 9.59375
rt 6.82421875
ol 1.29296875
▁group 2.376953125
. 0.48681640625
<0x0A> 0.95166015625
This 3.583984375
▁type 6.0546875
▁of 0.0186614990234375
▁study 1.75
▁is 1.201171875
▁the 3.326171875
▁most 1.990234375
▁reve 9.0
aling 0.040802001953125
▁and 1.0302734375
▁inclus 6.53515625
ive 0.0181884765625
, 2.337890625
▁as 1.966796875
▁it 0.337890625
▁contains 5.00390625
▁direct 6.70703125
▁responses 5.00390625
▁from 0.87109375
▁a 3.962890625
▁large 1.046875
▁number 0.489013671875
▁of 0.0073089599609375
▁participants 1.4091796875
. 0.658203125
▁All 4.578125
▁tools 9.3984375
▁in 4.35546875
▁the 0.6826171875
▁form 3.82421875
▁of 0.0447998046875
▁question 1.802734375
na 0.049285888671875
ires 0.00986480712890625
▁and 2.1015625
▁scales 3.3828125
▁have 3.728515625
▁already 4.6171875
▁been 0.1529541015625
▁used 1.96875
▁and 2.15625
▁proved 4.05859375
▁their 1.7333984375
▁effic 3.4140625
acy 0.016876220703125
▁for 3.55078125
▁collect 4.9140625
ing 0.025115966796875
▁analyt 8.421875
ical 0.40283203125
▁data 0.250732421875
. 0.457763671875
▁It 3.5390625
▁helps 4.80078125
▁to 0.92578125
▁system 7.2578125
at 1.0693359375
ize 0.041015625
▁and 1.552734375
▁class 4.125
ify 0.017364501953125
▁distinct 9.5390625
▁kinds 5.9765625
▁of 0.0254669189453125
▁information 3.390625
▁for 3.974609375
▁subsequent 4.29296875
▁un 7.8046875
comp 5.80859375
licated 0.1510009765625
▁services 11.515625
. 0.677734375
▁Thus 4.3125
, 0.030120849609375
▁research 4.578125
ers 0.54150390625
▁can 1.3671875
▁compare 4.01171875
▁the 1.0078125
▁effects 3.3359375
▁of 0.11297607421875
▁medic 4.5
ations 0.96484375
▁on 1.783203125
▁patients 2.11328125
▁of 4.48046875
▁diverse 3.98046875
▁age 2.75390625
▁groups 0.68310546875
, 0.92724609375
▁background 5.06640625
s 0.2198486328125
, 0.07708740234375
▁physical 5.453125
▁conditions 1.3623046875
, 0.09783935546875
▁emot 5.38671875
ional 0.06787109375
▁states 1.373046875
P 15.8671875
, 1.9072265625
▁and 0.71240234375
▁so 3.1171875
▁on 0.28759765625
. 0.09954833984375
<0x0A> 0.78125
The 1.23828125
▁analysis 4.609375
▁of 0.568359375
▁any 8.4296875
▁human 5.984375
▁reaction 4.81640625
▁has 4.53125
▁a 1.7294921875
▁high 4.30859375
▁potential 3.33984375
▁of 1.6875
▁subject 6.62109375
iveness 3.794921875
▁and 1.2958984375
▁bias 2.419921875
, 1.7314453125
▁especially 2.765625
▁regarding 4.56640625
▁people 4.4140625
▁in 3.9609375
▁severe 4.5
▁pain 0.3095703125
▁and 2.595703125
▁un 5.35546875
stable 1.7490234375
▁mot 10.390625
ional 4.7734375
▁condition 2.947265625
. 0.1348876953125
▁Perhaps 8.90625
▁some 5.07421875
▁patients 2.310546875
▁tend 5.50390625
▁to 0.02618408203125
▁ex 2.490234375
agger 0.014678955078125
ate 0.0115203857421875
▁their 0.72705078125
▁de 4.86328125
press 1.892578125
ive 0.44580078125
▁state 2.99609375
▁or 1.8193359375
▁vice 7.51171875
▁vers 0.06170654296875
a 0.01139068603515625
, 1.0576171875
▁de 7.46484375
- 4.35546875
emph 1.1591796875
as 0.023651123046875
ize 0.1683349609375
▁serious 6.76171875
▁difficulties 6.1796875
. 0.916015625
▁Because 6.13671875
▁the 2.294921875
▁survey 6.015625
▁responses 6.6328125
▁were 1.55859375
▁thoroughly 8.078125
▁anonymous 5.1875
, 0.460693359375
t 12.453125
▁he 4.34765625
▁research 1.47265625
ers 0.319580078125
▁were 1.4716796875
▁unable 2.388671875
▁to 0.04779052734375
▁carefully 8.546875
▁analyze 1.53125
▁each 3.8828125
▁patient 2.59375
’ 25.203125
s 0.908203125
▁reaction 3.712890625
▁and 2.4296875
▁compare 3.447265625
▁it 0.8623046875
▁to 1.26953125
▁the 0.79443359375
▁actual 5.40625
▁states 7.1953125
▁of 0.64404296875
▁condition 7.29296875
. 0.377685546875
▁More 6.8515625
▁accurate 4.04296875
▁answers 5.0
▁could 2.515625
▁be 0.8427734375
▁obtained 0.90673828125
▁by 1.3623046875
▁professional 7.625
▁psych 2.31640625
olog 0.37451171875
ists 0.0146026611328125
▁via 7.95703125
▁personal 3.91796875
▁communication 4.85546875
▁and 1.84765625
▁behavior 7.36328125
al 0.33740234375
▁analysis 2.1796875
. 0.24853515625
▁However 2.728515625
, 0.00662994384765625
▁this 1.9091796875
▁method 2.921875
▁of 2.228515625
▁research 2.12890625
▁is 0.89990234375
▁way 8.078125
▁more 1.5068359375
▁resource 6.625
- 0.5166015625
int 0.65576171875
ensive 0.013641357421875
▁and 0.63232421875
▁energy 8.546875
- 0.1480712890625
consum 0.346435546875
ing 0.01052093505859375
. 0.63720703125
<0x0A> 0.62744140625
Part 5.75390625
icip 0.125
ants 0.1578369140625
▁were 0.994140625
▁rec 1.650390625
ru 0.00896453857421875
ited 0.0018148422241210938
▁for 1.1064453125
▁six 0.93212890625
▁months 0.032257080078125
▁at 0.35400390625
▁two 0.097900390625
▁major 0.2322998046875
▁pain 0.034637451171875
▁relief 0.0267486572265625
▁cent 0.0181427001953125
ers 0.017486572265625
▁in 0.053466796875
▁Israel 0.0271759033203125
. 0.1309814453125
▁All 3.6171875
▁patients 1.642578125
▁experienced 5.40625
▁chron 1.8212890625
ic 0.00656890869140625
▁pain 0.1199951171875
▁for 3.392578125
▁at 0.79638671875
▁least 0.00806427001953125
▁ 1.0439453125
3 1.4208984375
▁months 0.2578125
. 0.998046875
▁The 1.4296875
▁study 1.8447265625
▁included 2.2109375
▁ 1.0927734375
8 2.876953125
9 2.8046875
0 3.556640625
▁participants 1.560546875
, 1.26171875
▁of 1.8046875
▁which 0.4228515625
▁ 0.1544189453125
4 1.6611328125
7 2.478515625
4 2.796875
▁( 2.27734375
5 0.130615234375
9 10.7578125
%) 0.92919921875
▁were 0.4765625
▁treated 4.6796875
▁sole 7.12109375
ly 0.0015363693237304688
▁with 0.475341796875
▁op 0.82421875
io 0.3935546875
ids 0.205078125
, 1.1005859375
▁ 0.5517578125
3 1.125
2 2.12890625
9 2.5234375
▁( 0.054046630859375
4 1.2900390625
1 1.28125
%) 0.1314697265625
▁were 1.328125
▁treated 0.432373046875
▁with 0.1981201171875
▁MM 0.94970703125
, 0.2261962890625
▁and 0.1524658203125
▁ 0.151123046875
7 3.166015625
7 2.431640625
▁( 0.20458984375
8 3.6953125
. 1.1845703125
6 3.01953125
%) 0.07196044921875
▁acquired 9.671875
▁both 1.0966796875
▁( 6.921875
Fe 9.9609375
ing 3.2734375
old 0.033050537109375
▁et 1.548828125
▁al 0.055999755859375
., 0.38330078125
▁ 0.0284881591796875
2 0.2056884765625
0 0.0037860870361328125
1 0.5078125
7 2.259765625
). 0.1539306640625
▁The 1.310546875
▁remaining 7.0859375
▁ten 8.328125
▁participants 1.3662109375
▁who 5.43359375
▁did 1.4736328125
▁not 0.0118408203125
▁receive 1.8466796875
▁ph 3.080078125
arma 0.066162109375
ce 0.00368499755859375
ut 0.0015745162963867188
ical 0.004604339599609375
▁op 0.90185546875
io 0.0804443359375
ids 0.0269622802734375
▁and 1.783203125
▁medical 2.435546875
▁mar 0.051849365234375
iju 0.0216217041015625
ana 0.0011053085327148438
▁were 1.2578125
▁with 6.078125
dra 0.21923828125
wn 0.0024700164794921875
▁from 0.274169921875
▁the 0.11834716796875
▁analysis 4.59765625
▁in 4.8828125
▁the 1.220703125
▁research 4.1796875
. 0.71484375
▁Therefore 4.875
, 0.0105743408203125
▁it 3.6953125
▁is 0.8486328125
▁not 2.666015625
▁possible 0.80810546875
▁to 0.0286712646484375
▁compreh 6.49609375
ens 0.08441162109375
ively 0.03271484375
▁compare 1.9462890625
▁patients 4.6875
▁taking 4.3671875
▁medic 3.921875
ations 0.436767578125
▁with 1.060546875
▁those 1.1875
▁who 1.1572265625
▁do 1.607421875
▁not 0.01239013671875
. 0.77880859375
<0x0A> 0.6318359375
The 1.169921875
▁study 1.6640625
▁conducted 4.76171875
▁a 2.287109375
▁correlation 6.25390625
▁type 7.5859375
▁of 0.45166015625
▁research 1.974609375
▁with 2.896484375
▁variable 7.8125
▁measures 4.859375
. 1.310546875
▁It 2.126953125
▁evaluated 4.46484375
▁the 0.5693359375
▁inter 6.109375
dep 3.763671875
end 0.02191162109375
ence 0.027862548828125
▁of 0.51806640625
▁various 4.09765625
▁factors 1.958984375
▁that 2.89453125
▁affected 4.20703125
▁the 0.59765625
▁physical 7.21875
▁and 0.966796875
▁emot 0.52197265625
ional 0.0011310577392578125
▁condition 1.1337890625
▁of 0.1143798828125
▁patients 0.62353515625
▁experien 4.2890625
cing 0.0009622573852539062
▁chron 0.56982421875
ic 0.0013189315795898438
▁pain 0.031768798828125
. 0.22802734375
▁For 4.00390625
▁example 1.1865234375
, 0.0203704833984375
▁the 1.2080078125
▁survey 5.015625
▁showed 3.263671875
▁that 0.3916015625
▁the 1.74609375
▁ratio 6.66796875
▁of 0.13671875
▁female 4.6640625
▁patients 0.7978515625
▁was 1.8369140625
▁remark 9.359375
ably 0.004817962646484375
▁higher 0.55224609375
▁in 2.71484375
▁the 0.87744140625
▁op 4.21484375
i 3.44140625
ates 0.450439453125
▁group 0.28515625
▁compared 2.6875
▁to 0.1390380859375
▁the 0.474853515625
▁MM 0.49267578125
▁group 0.222412109375
. 0.49951171875
▁In 2.96875
▁turn 4.22265625
, 0.005374908447265625
▁people 6.015625
▁on 5.5078125
▁op 1.4072265625
i 0.5029296875
ates 0.0086822509765625
▁were 1.0693359375
▁more 1.0009765625
▁likely 0.37060546875
▁to 0.06524658203125
▁report 3.169921875
▁major 6.01953125
▁de 0.5078125
press 1.2431640625
ive 0.00698089599609375
▁dis 0.541015625
orders 1.48046875
. 1.78125
<0x0A> 2.515625
The 1.1572265625
▁question 5.54296875
na 0.9599609375
ires 0.0032138824462890625
▁used 2.029296875
d 13.2734375
▁if 9.4140625
fer 6.41015625
ent 0.1624755859375
▁variable 7.40234375
▁measures 0.814453125
▁to 1.626953125
▁collect 2.779296875
▁information 2.015625
. 1.5859375
▁For 2.2109375
▁example 0.2432861328125
, 0.01123809814453125
▁it 4.05078125
▁included 2.8828125
▁compreh 8.59375
ensive 0.0304412841796875
▁so 6.609375
cio 0.36962890625
- 0.5986328125
dem 0.1358642578125
ographic 0.055023193359375
▁data 1.0751953125
: 4.83203125
▁gender 1.66015625
, 0.08526611328125
▁age 0.221435546875
, 0.09698486328125
▁country 4.4375
, 1.455078125
▁type 4.3984375
▁of 0.05633544921875
▁residence 3.87890625
▁( 3.408203125
urban 2.025390625
/ 2.80859375
r 0.0782470703125
ural 0.01187896728515625
), 0.219482421875
▁years 6.0390625
▁of 0.167236328125
▁education 0.75537109375
, 0.1517333984375
▁and 1.880859375
▁employ 3.83984375
ment 0.00910186767578125
▁status 0.451171875
. 0.1937255859375
▁Pat 4.30078125
ients 0.09228515625
▁were 1.15625
▁also 0.87353515625
▁asked 0.58984375
▁about 1.2314453125
▁their 0.60693359375
▁medical 2.8203125
▁history 0.434814453125
▁over 8.71875
▁the 0.164306640625
▁years 3.951171875
a 11.6171875
▁ 4.109375
nd 0.080322265625
▁the 2.064453125
▁current 3.45703125
▁presence 5.59375
▁of 0.06805419921875
▁any 2.521484375
▁severe 4.71875
▁dise 1.7861328125
ases 0.00600433349609375
▁such 4.02734375
▁as 0.017303466796875
▁heart 2.337890625
▁failure 2.046875
, 0.2003173828125
▁di 1.876953125
ab 0.00470733642578125
etes 0.007587432861328125
, 0.1527099609375
▁ar 3.75
th 0.1783447265625
rit 0.04931640625
is 0.0240478515625
, 0.07049560546875
▁and 1.625
▁so 0.76708984375
▁on 0.045654296875
. 0.046875
▁The 1.8515625
▁third 7.3203125
▁measure 4.2265625
▁of 1.88671875
▁the 0.9970703125
▁question 2.462890625
naire 0.3935546875
▁was 0.91064453125
▁indicated 9.578125
▁by 0.68310546875
▁n 8.3125
iform 14.4375
ation 4.2578125
▁on 2.134765625
▁any 5.4609375
▁twelve 13.828125
- 1.48046875
month 0.93017578125
▁and 6.1328125
▁lifetime 3.19140625
▁drug 4.34765625
▁and 3.51171875
▁alco 0.128173828125
hol 0.0015125274658203125
▁consumption 2.765625
. 0.480712890625
▁In 3.54296875
▁addition 0.7919921875
, 0.1319580078125
▁the 1.162109375
▁record 8.15625
▁included 1.7421875
▁a 2.322265625
▁pain 6.859375
▁measurement 4.34765625
▁scale 1.0634765625
▁from 3.814453125
▁ 0.416748046875
0 0.478515625
▁to 0.4599609375
▁ 0.01297760009765625
1 0.11138916015625
0 0.07928466796875
▁to 4.546875
▁evaluate 1.46875
▁dis 5.99609375
com 0.17724609375
fort 0.01171875
▁feelings 7.1953125
▁during 3.08203125
▁the 0.8994140625
▁last 1.4033203125
▁month 1.5498046875
. 0.31201171875
<0x0A> 0.97216796875
Am 6.76171875
ong 0.0234222412109375
▁all 2.26953125
▁particip 5.8046875
anst 6.55859375
▁in 5.68359375
▁the 0.2235107421875
▁study 0.42138671875
, 0.07208251953125
▁ 0.6494140625
4 1.6689453125
2 2.755859375
. 1.90625
2 2.2734375
% 0.164794921875
▁suff 10.0234375
eed 5.03515625
▁from 0.54248046875
▁de 3.361328125
pression 0.2030029296875
, 1.10546875
▁and 1.8837890625
▁ 0.1954345703125
3 1.724609375
7 2.189453125
% 2.595703125
▁exper 7.78515625
i 1.9951171875
ien 2.84375
ced 0.0125732421875
▁excess 7.76171875
ive 0.14599609375
▁anx 0.304931640625
iety 0.01052093505859375
. 0.374755859375
▁The 1.4013671875
▁pl 10.5
ur 1.2470703125
ality 0.007068634033203125
▁fo 11.4765625
▁de 4.7421875
press 1.798828125
ive 0.10382080078125
▁dis 1.35546875
orders 0.15966796875
▁among 4.15625
▁patients 1.271484375
▁in 3.798828125
▁the 0.3974609375
▁op 1.3662109375
i 1.01171875
ates 0.0169677734375
, 6.75
▁medical 2.482421875
▁mar 0.03656005859375
iju 0.05389404296875
ana 0.00189208984375
, 0.1287841796875
▁and 0.07415771484375
▁mixed 5.90234375
▁OP 8.3515625
MM 6.0234375
▁groups 0.47216796875
▁number 8.2109375
ed 0.015838623046875
▁ 0.1329345703125
5 2.294921875
7 2.53125
. 0.2430419921875
1 2.3984375
%, 0.248046875
▁ 0.01039886474609375
2 2.966796875
2 2.462890625
. 0.0867919921875
3 2.25
%, 0.12359619140625
▁and 0.048919677734375
▁ 0.008026123046875
5 3.16796875
1 2.568359375
. 0.175537109375
4 2.13671875
%, 0.399169921875
▁respectively 0.044677734375
. 0.24072265625
▁The 1.4521484375
▁pl 4.05859375
ur 0.046173095703125
ality 0.0005159378051757812
▁of 0.2398681640625
▁an 5.97265625
ix 8.421875
ety 2.541015625
▁contained 10.5703125
▁ 1.0078125
4 1.6201171875
8 2.427734375
. 0.06219482421875
4 2.302734375
% 0.50830078125
▁among 1.4541015625
▁OP 6.51171875
▁patients 8.6640625
, 0.27734375
▁ 0.119140625
2 1.5498046875
1 2.423828125
. 0.14453125
5 2.396484375
% 0.01444244384765625
▁among 0.441650390625
▁MM 0.41357421875
▁patients 0.2310791015625
, 0.01143646240234375
▁and 0.02484130859375
▁ 0.040740966796875
3 1.23828125
8 2.603515625
. 0.14697265625
7 2.255859375
% 0.016143798828125
▁among 0.253173828125
▁OP 3.712890625
MM 0.263671875
▁participants 3.76171875
. 0.1805419921875
▁Pat 5.68359375
ients 0.03094482421875
▁who 2.37890625
▁took 2.712890625
▁strong 8.3125
▁op 1.064453125
i 1.36328125
ates 0.0109100341796875
▁were 1.830078125
▁t 8.0078125
ended 1.8193359375
▁to 0.0282745361328125
▁place 10.3125
▁their 3.787109375
▁pain 2.41015625
▁on 3.44921875
▁a 0.76806640625
▁scale 2.388671875
▁of 0.66015625
▁ 0.29931640625
9 2.880859375
▁to 1.18359375
▁ 0.0193634033203125
1 0.0249786376953125
0 0.0806884765625
▁( 2.525390625
Fe 1.86328125
ing 0.02337646484375
old 0.004184722900390625
▁et 0.0275421142578125
▁al 0.0098419189453125
., 0.011962890625
▁ 0.006397247314453125
2 0.0009598731994628906
0 0.0005021095275878906
1 0.00376129150390625
7 0.0213775634765625
). 0.0535888671875
▁They 4.99609375
▁were 1.34765625
▁also 1.396484375
▁an 8.734375
gu 5.9765625
ished 0.060028076171875
▁em 8.3671875
otion 0.11187744140625
ally 0.0194244384765625
▁and 1.259765625
▁react 7.07421875
ed 0.04937744140625
▁rad 9.2734375
ically 0.0823974609375
▁neg 5.30078125
atively 0.011444091796875
▁to 0.35302734375
▁almost 5.3203125
▁all 1.2177734375
▁survey 8.296875
▁q 10.3046875
A 6.0546875
u 2.544921875
estions 0.035491943359375
. 0.386962890625
▁Pat 4.51171875
ients 0.01224517822265625
▁who 1.15234375
▁took 1.4814453125
▁only 5.73828125
▁MM 0.892578125
▁or 3.2890625
▁mixed 3.5234375
▁medic 2.75
ations 0.317626953125
▁course 12.4296875
▁had 2.369140625
▁a 1.296875
▁significantly 2.7109375
▁more 3.923828125
▁stable 3.271484375
▁emot 1.435546875
ional 0.01265716552734375
▁state 0.779296875
▁and 1.62109375
▁cop 5.73046875
ed 1.158203125
▁with 0.76953125
▁pain 1.376953125
▁more 1.5859375
▁manage 6.76953125
able 2.51953125
. 0.51611328125
<0x0A> 0.634765625
One 5.2109375
▁of 0.56689453125
▁the 0.0276641845703125
▁major 2.533203125
▁limitations 2.861328125
▁is 4.05859375
▁the 0.54931640625
▁ins 4.75390625
u 0.05682373046875
fficient 0.134521484375
ly 4.91796875
▁high 3.083984375
▁response 3.0
▁rate 0.1336669921875
, 2.650390625
▁ 4.4296875
5 2.03125
7 2.08203125
% 1.998046875
▁instead 7.3671875
▁of 0.0186004638671875
▁ 0.73583984375
7 1.5302734375
0 1.626953125
% 1.0712890625
▁( 1.7666015625
Fe 0.2841796875
ing 0.01776123046875
old 0.004802703857421875
▁et 0.007843017578125
▁al 0.00882720947265625
., 0.01003265380859375
▁ 0.004604339599609375
2 0.0009512901306152344
0 0.0003147125244140625
1 0.0023670196533203125
7 0.0111236572265625
). 0.035675048828125
▁It 2.734375
▁can 3.240234375
▁be 0.361328125
▁fairly 8.3828125
▁explained 1.609375
▁by 0.21240234375
▁the 0.3388671875
▁weak 8.2265625
▁focus 7.0859375
▁of 0.45263671875
▁respond 6.328125
ents 0.1448974609375
▁who 3.5
▁have 4.30078125
▁overcome 7.9921875
▁severe 2.345703125
▁pain 0.52685546875
▁sens 8.4375
ations 1.1640625
▁and 1.236328125
▁de 4.33984375
press 1.5322265625
ive 0.2008056640625
▁episodes 4.3203125
. 0.6044921875
▁It 3.361328125
▁is 0.82421875
▁not 2.611328125
▁clear 4.37109375
▁how 1.662109375
▁to 3.640625
▁use 5.3671875
▁these 2.927734375
▁statistics 3.5234375
, 2.482421875
▁as 1.2939453125
▁they 1.2900390625
▁still 6.296875
▁may 4.69921875
▁be 1.3173828125
▁relevant 5.6640625
▁for 1.4150390625
▁the 1.814453125
▁overall 4.41015625
▁analysis 3.126953125
. 0.994140625
